InTest Reports Orders Improved 10% and Gross Margin Expanded 110 basis points Sequentially to 42.6% for Second Quarter 2025
Financial Performance Overview: InTest Corporation reported a 6% year-over-year increase in orders, driven by growth in the automotive/EV and life sciences sectors, while revenue rose to $28.1 million sequentially. The company narrowed its operating loss to $0.9 million and reduced total debt by $1.7 million.
Market Outlook and Strategy: Despite ongoing economic uncertainties, InTest remains focused on its VISION 2030 Growth Strategy, emphasizing innovation and market diversification. The company anticipates continued growth in the third quarter of 2025, with projected revenues between $28 million and $30 million.
Trade with 70% Backtested Accuracy
Analyst Views on INTT
About INTT
About the author
inTest Corporation (INTT) Shares Surge 8.9% Amid Record Order Growth
- Stock Performance: inTest Corporation's shares rallied 8.9% in the last trading session to close at $8.72, with notable trading volume indicating strong market confidence in its future performance.
- Order Growth: The company is benefiting from record order growth and robust demand in the auto, EV, and defense sectors, supporting expectations for a gradual recovery, despite a quarterly EPS estimate of $0.16, reflecting a 30.4% year-over-year decline.
- Revenue Expectations: Expected revenues of $31.74 million represent a 13.3% decline from the previous year, yet optimism remains due to successful new product adoption and higher conversion rates, which may drive future growth.
- Analyst Rating: Currently holding a Zacks Rank of #3 (Hold), inTest's stock may struggle to maintain upward momentum in the absence of earnings estimate revisions, prompting investors to closely monitor upcoming developments.
InTest CEO to Participate in 14th Annual NYC Summit
- Executive Participation: InTest's President and CEO Nick Grant, along with CFO Duncan Gilmour, will attend the 14th Annual NYC Summit on December 16, 2025, at Mastro's Steakhouse in New York, showcasing the company's innovative technologies in key markets such as semiconductors, automotive, and life sciences.
- Investor Engagement: The summit will feature a
InTest Secures $3.7M Order to Expand Medical Device Testing
- Order Expansion: InTest Corporation has secured a follow-on $3.7 million order from an existing customer, aimed at providing additional functional test systems for medical device manufacturers, thereby enhancing its market presence in the life sciences sector.
- Automated Testing Solutions: Alfamation will supply multiple conveyor-based testing systems equipped with high-precision instruments and fixtures, which will enhance testing efficiency and support the testing of 50 million devices annually, significantly increasing production capacity.
- Critical Technical Capability: This order highlights Alfamation's expertise in performing high-performance electrical measurements at the PCB level, which is crucial for products that cannot be evaluated when fully assembled, ensuring the safety and effectiveness of medical devices.
- Strategic Growth: InTest's growth strategy is further validated by this order, indicating that its expansion into the medical device sector relies not only on technological innovation but also on organic growth through acquisitions and market penetration.
Momentum Stock inTest (INTT) Remains a Bargain Despite Rapid Growth
Momentum Investing Overview: Momentum investing involves buying high and selling higher, contrasting with the traditional strategy of buying low and selling high. This approach can be risky as stocks may lose momentum if their valuations exceed future growth potential.
inTest Corporation (INTT) Highlights: INTT has shown strong price momentum with a 9.1% increase over four weeks and a 3.5% gain over 12 weeks. It has a favorable Momentum Score of B and is trading at a reasonable valuation, making it a strong candidate for momentum investing.
Quantum Computing Potential: Quantum computing is rapidly advancing, with major tech companies integrating it into their infrastructure. Experts believe it could surpass AI in technological impact, presenting investment opportunities in this emerging field.
Investment Tools and Resources: Zacks Investment Research offers various tools, including the 'Fast-Paced Momentum at a Bargain' screen and the Research Wizard, to help investors identify promising stocks and backtest their strategies for better market performance.
6 Undervalued Semiconductor and Software Stocks Showing Promising Value Indicators
Investment Strategies: Investors are divided between those seeking high-growth stocks and those looking for value in quality companies trading at a discount, with a focus on identifying undervalued stocks.
Benzinga's Value Rankings: Benzinga's Edge Rankings system evaluates stocks based on momentum, growth, quality, and value, using traditional metrics like P/E, P/S, and P/B ratios to identify potentially undervalued stocks.
Highlighted Stocks: Six software and semiconductor stocks have shown significant increases in their value rankings recently, including IPG Photonics Corp., inTest Corp., Mogo Inc., Marqeta Inc., Synaptics Inc., and LiveRamp Holdings Inc.
Market Trends: The SPDR S&P 500 ETF Trust and Invesco QQQ Trust ETF experienced slight declines in premarket trading, indicating potential market volatility amidst these investment opportunities.
Fast-paced Momentum Stock inTest (INTT) Is Still Trading at a Bargain
Momentum Investing Strategy: Momentum investors focus on "buying high and selling higher" rather than traditional strategies of buying low, which can be risky if stocks lose momentum. A safer approach is to invest in bargain stocks that show recent price momentum, like inTest Corporation (INTT), which has demonstrated strong performance and favorable valuation metrics.
Investment Recommendations: INTT has a high Momentum Score and Zacks Rank #2 (Buy), indicating it is a promising investment opportunity. Additionally, there are other stocks that meet the criteria for fast-paced momentum at attractive prices, and tools like the Zacks Research Wizard can help investors identify successful stock-picking strategies.
inTest Corporation (INTT) Shares Surge 8.9% Amid Record Order Growth
- Stock Performance: inTest Corporation's shares rallied 8.9% in the last trading session to close at $8.72, with notable trading volume indicating strong market confidence in its future performance.
- Order Growth: The company is benefiting from record order growth and robust demand in the auto, EV, and defense sectors, supporting expectations for a gradual recovery, despite a quarterly EPS estimate of $0.16, reflecting a 30.4% year-over-year decline.
- Revenue Expectations: Expected revenues of $31.74 million represent a 13.3% decline from the previous year, yet optimism remains due to successful new product adoption and higher conversion rates, which may drive future growth.
- Analyst Rating: Currently holding a Zacks Rank of #3 (Hold), inTest's stock may struggle to maintain upward momentum in the absence of earnings estimate revisions, prompting investors to closely monitor upcoming developments.
InTest CEO to Participate in 14th Annual NYC Summit
- Executive Participation: InTest's President and CEO Nick Grant, along with CFO Duncan Gilmour, will attend the 14th Annual NYC Summit on December 16, 2025, at Mastro's Steakhouse in New York, showcasing the company's innovative technologies in key markets such as semiconductors, automotive, and life sciences.
- Investor Engagement: The summit will feature a
InTest Secures $3.7M Order to Expand Medical Device Testing
- Order Expansion: InTest Corporation has secured a follow-on $3.7 million order from an existing customer, aimed at providing additional functional test systems for medical device manufacturers, thereby enhancing its market presence in the life sciences sector.
- Automated Testing Solutions: Alfamation will supply multiple conveyor-based testing systems equipped with high-precision instruments and fixtures, which will enhance testing efficiency and support the testing of 50 million devices annually, significantly increasing production capacity.
- Critical Technical Capability: This order highlights Alfamation's expertise in performing high-performance electrical measurements at the PCB level, which is crucial for products that cannot be evaluated when fully assembled, ensuring the safety and effectiveness of medical devices.
- Strategic Growth: InTest's growth strategy is further validated by this order, indicating that its expansion into the medical device sector relies not only on technological innovation but also on organic growth through acquisitions and market penetration.
Momentum Stock inTest (INTT) Remains a Bargain Despite Rapid Growth
Momentum Investing Overview: Momentum investing involves buying high and selling higher, contrasting with the traditional strategy of buying low and selling high. This approach can be risky as stocks may lose momentum if their valuations exceed future growth potential.
inTest Corporation (INTT) Highlights: INTT has shown strong price momentum with a 9.1% increase over four weeks and a 3.5% gain over 12 weeks. It has a favorable Momentum Score of B and is trading at a reasonable valuation, making it a strong candidate for momentum investing.
Quantum Computing Potential: Quantum computing is rapidly advancing, with major tech companies integrating it into their infrastructure. Experts believe it could surpass AI in technological impact, presenting investment opportunities in this emerging field.
Investment Tools and Resources: Zacks Investment Research offers various tools, including the 'Fast-Paced Momentum at a Bargain' screen and the Research Wizard, to help investors identify promising stocks and backtest their strategies for better market performance.
6 Undervalued Semiconductor and Software Stocks Showing Promising Value Indicators
Investment Strategies: Investors are divided between those seeking high-growth stocks and those looking for value in quality companies trading at a discount, with a focus on identifying undervalued stocks.
Benzinga's Value Rankings: Benzinga's Edge Rankings system evaluates stocks based on momentum, growth, quality, and value, using traditional metrics like P/E, P/S, and P/B ratios to identify potentially undervalued stocks.
Highlighted Stocks: Six software and semiconductor stocks have shown significant increases in their value rankings recently, including IPG Photonics Corp., inTest Corp., Mogo Inc., Marqeta Inc., Synaptics Inc., and LiveRamp Holdings Inc.
Market Trends: The SPDR S&P 500 ETF Trust and Invesco QQQ Trust ETF experienced slight declines in premarket trading, indicating potential market volatility amidst these investment opportunities.
Fast-paced Momentum Stock inTest (INTT) Is Still Trading at a Bargain
Momentum Investing Strategy: Momentum investors focus on "buying high and selling higher" rather than traditional strategies of buying low, which can be risky if stocks lose momentum. A safer approach is to invest in bargain stocks that show recent price momentum, like inTest Corporation (INTT), which has demonstrated strong performance and favorable valuation metrics.
Investment Recommendations: INTT has a high Momentum Score and Zacks Rank #2 (Buy), indicating it is a promising investment opportunity. Additionally, there are other stocks that meet the criteria for fast-paced momentum at attractive prices, and tools like the Zacks Research Wizard can help investors identify successful stock-picking strategies.
